SCHEMBL6274988

SCHEMBL6274988

CCOC(=O)c1cc2c(Cl)c(Oc3ccc(O)c(S(=O)(=O)NC4CCC4)c3)c(Cl)cc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 7/20 0.51
▸ THRA P10827 3/20 0.47
▸ LGALS8 O00214 1/20 0.37
▸ LGALS3 P17931 1/20 0.37
▸ LMNA P02545 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ BRD2 P25440 1/20 0.36
▸ BRD3 Q15059 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ ALOX15 P16050 1/20 0.35
▸ CCR8 P51685 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6272088 0.90 THRB (0.43) THRBTHRALGALS8LGALS3LMNA
SCHEMBL1641445 0.88 THRB (0.58) THRBTHRAALDH1A1BRD4BRD2
SCHEMBL6274126 0.86 THRB (0.55) THRBTHRALGALS8LGALS3LMNA
SCHEMBL1640579 0.85 THRB (0.59) THRBTHRALGALS8
SCHEMBL6270954 0.85 THRB (0.54) THRBTHRALGALS8LGALS3LMNA
SCHEMBL6270967 0.80 THRB (0.51) THRBTHRABRD4BRD2BRD3
SCHEMBL6273242 0.78 THRB (0.49) THRBTHRABRD4BRD2BRD3
SCHEMBL6655785 0.77 THRB (0.53) THRBTHRALMNABRD4BRD2
SCHEMBL6275907 0.77 THRA (0.77) THRBTHRA
SCHEMBL1642115 0.77 THRB (0.47) THRBTHRAALDH1A1BRD4BRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1297833-B1 Indole carboxylic acids as thyroid receptor ligands PFIZER PROD INC (US) 2005-12-21 — — EP disclosed
US-6723744-B2 FOR THERAPY OF OBESITY, OVERWEIGHT CONDITION, HYPERLIPIDEMIA, GLAUCOMA, CARDIAC ARRHYTHMIAS, SKIN DISORDER, THYROID DISEASE, HYPOTHYROIDISM, THYROID CANCER, DIABETES, ATHEROSCLEROSIS, HYPERTENSION, CORONARY HEART DISEASE, HYPERCHOLESTEREMIA PFIZER, INC. 2004-04-20 — — US disclosed
US-20030078289-A1 Indole carboxylic acids as thyroid receptor ligands ASPNES GARY E (US) 2003-04-24 — — US disclosed
EP-1297833-A1 Indole carboxylic acids as thyroid receptor ligands Pfizer Products Inc. (US) 2003-04-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078289-A1 Indole carboxylic acids as thyroid receptor ligands THRA, MC1R, THRB THRB 3/4885THRA 1/4885LGALS8 1888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback